Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.21.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2021
Sep. 30, 2020
Current Assets    
Cash and cash equivalents $ 344.9 $ 302.2
Trade receivables, net 293.4 279.5
Receivables from long-term manufacturing contracts 149.2 138.1
Inventories, net 385.0 385.4
Prepaid expenses and other current assets 82.6 83.2
Current assets held for sale 62.7 181.3
Total current assets 1,317.8 1,369.7
Property, plant, and equipment, net 296.4 314.2
Operating lease right-of-use assets 150.6 154.4
Intangible assets, net 939.1 960.7
Goodwill 1,165.9 1,137.8
Other long-term assets 47.3 50.6
Total Assets 3,917.1 3,987.4
Current Liabilities    
Trade accounts payable 293.8 271.6
Liabilities from long-term manufacturing contracts and advances 265.6 189.1
Current portion of long-term debt 0.0 36.3
Accrued compensation 95.6 96.1
Current liabilities held for sale 18.7 32.5
Other current liabilities 246.8 226.5
Total current liabilities 920.5 852.1
Long-term debt 1,211.9 1,516.3
Accrued pension and postretirement healthcare 163.8 166.8
Operating lease liabilities 116.4 120.9
Deferred income taxes 199.3 185.8
Other long-term liabilities 69.5 66.1
Total Liabilities 2,681.4 2,908.0
Commitments and contingencies (Note 15)
SHAREHOLDERS’ EQUITY    
Common stock, no par value (75.8 and 75.8 shares issued, 75.2 and 74.8 shares outstanding) 0.0 0.0
Additional paid-in capital 720.5 723.6
Retained earnings 603.1 481.4
Treasury stock (0.6 and 1.0 shares) (23.4) (43.2)
Accumulated other comprehensive loss (85.8) (102.8)
Hillenbrand Shareholders’ Equity 1,214.4 1,059.0
Noncontrolling interests 21.3 20.4
Total Shareholders’ Equity 1,235.7 1,079.4
Total Liabilities and Shareholders’ Equity $ 3,917.1 $ 3,987.4